Health
Study Identifies Cytokine Target for Treatment-Resistant Hemophilia A – MD Magazine
Elevated B cell activating factor levels in children and adults were associated with the development of FVIII inhibitors, which may lead to FVIII infusion failures….
Findings from a new study shed light on the mechanisms behind patient unresponsiveness to coagulation protein therapy for hemophilia A.
More specifically, investigators note a key target that may lead to treatment failure in up to 30% of patients.
Currently, hemophilia is the most common inherited bleeding disorder, which affects 1 in 10,000 men across the globe. Since patients lack coagulation factor VIII (FVIII), therapies are typically aimed at infusions to replace the missing protein.
Some patients,…
-
Business24 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
General21 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News15 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoRock royalty is rolling into Hervey Bay